The prospective study of absolute quantitation of KRAS mutaition in cell free plasma DNA with pancreatic ductal adenocarcinoma.
Not Applicable
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000017586
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who have another malignancies simultaneously. 2)Subjects who is participating in another clinical trial affect to primary or secondary end-point of this study 3)Subjects whose Hb levels were less than 7 g/dL 4)Subject who is judged to be ineligible due to subject's background, physical findings, medical examination, physical and clinical examination by principal investigator or sub investigator.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method